Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does OLANZAPINE Cause Hypoxic-ischaemic encephalopathy? 42 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Hypoxic-ischaemic encephalopathy have been filed in association with OLANZAPINE (Olanzapine). This represents 0.1% of all adverse event reports for OLANZAPINE.

42
Reports of Hypoxic-ischaemic encephalopathy with OLANZAPINE
0.1%
of all OLANZAPINE reports
28
Deaths
23
Hospitalizations

How Dangerous Is Hypoxic-ischaemic encephalopathy From OLANZAPINE?

Of the 42 reports, 28 (66.7%) resulted in death, 23 (54.8%) required hospitalization, and 27 (64.3%) were considered life-threatening.

Is Hypoxic-ischaemic encephalopathy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for OLANZAPINE. However, 42 reports have been filed with the FAERS database.

What Other Side Effects Does OLANZAPINE Cause?

Drug ineffective (5,139) Weight increased (3,588) Off label use (3,256) Toxicity to various agents (3,175) Somnolence (2,612) Sedation (2,130) Suicide attempt (2,116) Confusional state (1,898) Condition aggravated (1,810) Overdose (1,765)

What Other Drugs Cause Hypoxic-ischaemic encephalopathy?

MORPHINE (72) METHADONE (69) OXYCODONE (69) GABAPENTIN (65) FENTANYL (61) ACETAMINOPHEN (58) DIAZEPAM (55) ONDANSETRON (48) TRAMADOL (48) METFORMIN (45)

Which OLANZAPINE Alternatives Have Lower Hypoxic-ischaemic encephalopathy Risk?

OLANZAPINE vs OLANZAPINE\SAMIDORPHAN L-MALATE OLANZAPINE vs OLAPARIB OLANZAPINE vs OLARATUMAB OLANZAPINE vs OLECLUMAB OLANZAPINE vs OLIVE OIL\SOYBEAN OIL

Related Pages

OLANZAPINE Full Profile All Hypoxic-ischaemic encephalopathy Reports All Drugs Causing Hypoxic-ischaemic encephalopathy OLANZAPINE Demographics